Open AccessEvaluation of 48-week response of treatment-naive chronic hepatitis B patients to 0.5 mg/day entecavir
Author(s) -
Servet KÖLGELİER,
Nazlım Aktuğ Demir,
Serap Özçimen,
Şua Sümer
Publication year - 2014
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-1211-66
Subject(s) - medicine , entecavir , hbeag , chronic hepatitis , gastroenterology , cirrhosis , hepatitis b , hepatitis b virus , hepatocellular carcinoma , immunology , virus , hbsag , lamivudine
doi:10.3906/sag-1211-66 Evaluation of 48-week response of treatment-naive chronic hepatitis B patients to 0.5 mg/day entecavi
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom